$180 Million is the total value of Prosight Management, LP's 34 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 42.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KURA | Buy | KURA ONCOLOGY INC | $13,473,000 | -21.2% | 888,152 | +2.3% | 7.47% | -13.2% |
| QURE | Buy | UNIQURE NV | $12,949,000 | +38.1% | 328,978 | +174.1% | 7.18% | +51.9% |
| UTHR | Buy | UNITED THERAPEUTICS CORP | $10,602,000 | +1480.0% | 132,937 | +1445.8% | 5.88% | +1639.9% |
| URGN | Buy | UROGEN PHARMA LTD | $7,754,000 | -17.3% | 325,385 | +24.7% | 4.30% | -9.0% |
| CNC | Buy | CENTENE CORP | $7,138,000 | +7.6% | 165,000 | +30.4% | 3.96% | +18.4% |
| ACIU | Buy | AC IMMUNE SA | $6,180,000 | +97.4% | 1,248,453 | +121.4% | 3.43% | +117.2% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $6,063,000 | +38.3% | 89,952 | +75.7% | 3.36% | +52.1% |
| MGTX | New | MEIRAGTX HOLDINGS PLC | $5,393,000 | – | 338,096 | +100.0% | 2.99% | – |
| ALDX | Buy | ALDEYRA THERAPEUTICS INC | $4,165,000 | -0.5% | 790,228 | +13.2% | 2.31% | +9.4% |
| RCM | New | R1 RCM INC | $3,652,000 | – | 408,958 | +100.0% | 2.03% | – |
| HUM | New | HUMANA INC | $3,068,000 | – | 12,000 | +100.0% | 1.70% | – |
| ABBV | New | ABBVIE INC | $2,953,000 | – | 39,000 | +100.0% | 1.64% | – |
| CBIO | Buy | CATALYST BIOSCIENCES INC | $2,741,000 | -32.0% | 558,159 | +2.0% | 1.52% | -25.2% |
| GH | New | GUARDANT HEALTH INC | $2,662,000 | – | 41,700 | +100.0% | 1.48% | – |
| ARQL | Buy | ARQULE INC | $2,616,000 | +184.0% | 364,797 | +336.0% | 1.45% | +212.7% |
| ADMA | Buy | ADMA BIOLOGICS INC | $2,440,000 | +239.4% | 548,409 | +195.3% | 1.35% | +272.7% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $2,309,000 | -65.5% | 587,626 | +30.6% | 1.28% | -62.0% |
| PSNL | Buy | PERSONALIS INC | $1,691,000 | +10.3% | 115,214 | +104.1% | 0.94% | +21.3% |
| MTEM | Buy | MOLECULAR TEMPLATES INC | $1,470,000 | -11.0% | 222,994 | +12.8% | 0.82% | -2.0% |
| New | REATA PHARMACEUTICALS INCcall | $988,000 | – | 12,300 | +100.0% | 0.55% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ALDEYRA THERAPEUTICS INC | 19 | Q2 2023 | 6.2% |
| ALBIREO PHARMA INC | 18 | Q4 2022 | 9.2% |
| MEIRAGTX HOLDINGS PLC | 18 | Q3 2023 | 6.3% |
| KEZAR LIFE SCIENCES INC | 17 | Q3 2023 | 8.2% |
| ARENA PHARMACEUTICALS INC | 16 | Q4 2021 | 8.2% |
| IOVANCE BIOTHERAPEUTICS INC | 16 | Q1 2022 | 7.7% |
| CENTENE CORP DEL | 16 | Q3 2023 | 5.3% |
| CUE BIOPHARMA INC | 14 | Q1 2023 | 5.6% |
| PROTHENA CORP PLC | 13 | Q3 2023 | 13.6% |
| ZIMMER BIOMET HOLDINGS INC | 13 | Q3 2021 | 9.8% |
View Prosight Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| EXICURE, INC. | February 14, 2022 | 2,426,508 | 2.2% |
| Aldeyra Therapeutics, Inc. | February 12, 2021 | 908,488 | 2.3% |
| Teligent, Inc. | February 14, 2020 | 1,484,527 | 2.8% |
| Cidara Therapeutics, Inc. | February 14, 2019 | 245,764 | 0.9% |
| Eiger BioPharmaceuticals, Inc.Sold out | February 14, 2019 | 0 | 0.0% |
| Millendo Therapeutics, Inc. | February 14, 2019 | 256,739 | 2.0% |
| OvaScience, Inc. | October 26, 2018 | 1,991,100 | 5.6% |
| CHIMERIX INC | February 13, 2018 | 1,478,519 | 3.1% |
| Harvard Apparatus Regenerative Technology, Inc. | February 12, 2016 | 184,360 | 1.4% |
View Prosight Management, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-05-03 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G | 2024-01-02 |
| 13F-HR | 2023-11-14 |
View Prosight Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.